Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Southampton NHS Foundation Trust

About this trial

Plenty of studies have now established the safety of low-risk penicillin allergy de-labelling, but few have addressed how to organise de-labelling at the clinic level. This study will test the real world practicalities of running a de-labelling clinic optimised for maximum patient volume. The sheer number of patients with a penicillin allergy label, in contrast to relatively few allergy centres, makes demonstrating that such an approach can work extremely important for future antimicrobial stewardship.

Eligibility criteria

Qualifiers

Penicillin allergy label

Age ≥18

Registered as a patient with University Hospital Southampton NHS Foundation Trust (with a UHS medical record)

Able and willing to consent to penicillin de-labelling

Disqualifiers

Penicillin allergy previously confirmed via positive blood, skin, BAT or challenge testing

PEN-FAST score >2 (indicating a moderate or high risk of a positive challenge)

Anaphylaxis, angioedema, wheeze, shortness of breath or suspected hypotension linked to treatment with penicillin

Received treatment in hospital for a reaction linked to penicillin (unless already an inpatient at onset)

Trial design

Treatments tested in this trial

  • Single dose low-risk penicillin challenge

Treatment groups

No treatment groups listed

Locations

This trial has no locations